Purchases and Sales Made in Q4 2023 in Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY) during Q4 2023. The information is specifically focused on institutions that hold shares of Inozyme Pharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
6.25K+ 74.08% |
$16.9K - $28.1K
|
14.7K
$44.4K
|
|
|
Feb 12, 2024
Q4 2023
|
Invesco Ltd.
Atlanta, GA |
BUY
|
- |
4.8K+ 36.75% |
$13K - $21.6K
|
17.8K
$53.9K
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
BUY
|
- |
4.24K+ 7.14% |
$11.5K - $19.1K
|
63.7K
$192K
|
|
|
Feb 14, 2024
Q4 2023
|
Ameritas Investment Partners, Inc.
Lincoln, NE |
BUY
|
- |
2.01K+ 71.91% |
$5.45K - $9.05K
|
4.81K
$14.5K
|
|
|
Feb 15, 2024
Q4 2023
|
Legal & General Group PLC
London, X0 |
BUY
|
- |
1.05K+ 35.34% |
$2.85K - $4.74K
|
4.03K
$12.2K
|
|
|
Feb 14, 2024
Q4 2023
|
Metropolitan Life Insurance CO
New York, NY |
BUY
|
- |
1.01K+ 53.83% |
$2.73K - $4.53K
|
2.88K
$8.68K
|
|
|
Feb 09, 2024
Q4 2023
|
Parallel Advisors, LLC
|
BUY
|
- |
406+ 2.6% |
$1.1K - $1.83K
|
16K
$48.4K
|
|
|
Feb 13, 2024
Q4 2023
|
California State Teachers Retirement System
West Sacramento, CA |
BUY
|
- |
389+ 5.21% |
$1.05K - $1.75K
|
7.86K
$23.7K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 01, 2024
Q4 2023
|
New York State Common Retirement Fund
|
SELL
|
- |
-74- 0.55% |
$201 - $333
|
13.3K
$40.2K
|
|
|
Feb 06, 2024
Q4 2023
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-340- 10.33% |
$921 - $1.53K
|
2.95K
$8.92K
|
|
|
Feb 13, 2024
Q4 2023
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-3.11K- 0.95% |
$8.42K - $14K
|
324K
$978K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-4.44K- 53.29% |
$12K - $20K
|
3.89K
$11.8K
|
|
|
Jan 19, 2024
Q4 2023
|
Denali Advisors LLC
|
SELL
|
- |
-4.7K- 17.6% |
$12.7K - $21.2K
|
22K
$66.4K
|
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-14.4K- 21.15% |
$39K - $64.8K
|
53.7K
$162K
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-25.4K- 26.43% |
$68.8K - $114K
|
70.7K
$214K
|
|
|
Feb 14, 2024
Q4 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-39.9K- 43.5% |
$108K - $179K
|
51.8K
$156K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-77.1K- 26.08% |
$209K - $347K
|
219K
$660K
|
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-203K- 65.15% |
$551K - $914K
|
109K
$328K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.29M- 58.69% |
$3.51M - $5.83M
|
911K
$2.75M
|